Tool effective for rapid cataract screening

Article

Catatrac may be a low-cost and effective tool for the rapid screening of visually significant cataracts in the developing world, claims a paper in the journal Eye.

Catatrac may be a low-cost and effective tool for the rapid screening of visually significant cataracts in the developing world, claims a paper in the journal Eye.

A team led by Dr M.Q. Rahman, Tennent Institute of Ophthalmology, Gartnavel General Hospital, Glasgow, UK, divided 122 eyes of 73 patients into two groups- mild cataracts with logMAR acuities of less than 0.48 and advanced cataracts with logMAR acuities greater than or equal to 0.48.

All patients were assessed without pharmacological dilation in a dimly lit room. A slit lamp was used to examine each patient and the LOCS III classification system was used to grade cataracts.

Of the patients studied, 39 had mild cataracts, 43 eyes had advanced cataracts and there were 40 control eyes with no cataracts. The Catatrac device had a specificity of 95%, a sensitivity of 71 to 84.6% and κ values between 0.67 and 0.80 for agreement with slit lamp assessment.

Overall, the Catatrac device has a slightly lower sensitivity for mild cataracts the authors state it may be an efficient and cheap tool for screening visually significant cataracts in the developing world.

To read the abstract visit the website.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Jeremiah Tao, MD, FACS, discusses his Egyptian Ophthalmological Society keynote, which focused on risk management and avoiding surgical complications in oculofacial surgery
Omer Trivizki, MD, MBA, a retina specialist from Tel Aviv Medical Center, speaks about VOY-101, a Novel, Complement-Modulating Gene Therapy for Geographic Atrophy at the American Society of Retina Specialists (ASRS) Annual Meeting
João Pedro Marques, MD, MSc, PhD discusses a retrospective study of 800 patients with inherited retinal diseases during the American Society of Retina Specialists (ASRS) annual meeting
© 2025 MJH Life Sciences

All rights reserved.